Gilead's China Remdesivir Patents Confirmed, Generics Firms Cautioned

US Firm Gains Upper Hand Amid Patent Dispute

 
• By Brian Yang
  
Gilead. Maine. USA
GILEAD'S REMDESIVIR GETS CHINA PATENTS WHILE GENERICS ARE DISCOURAGED • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia